Kempharm, INC.
Pharmaceutical company engaged in the discovery and development of proprietary prodrugs
Based in IA
AI Overview
With $70K in lobbying spend across 3 quarterly filings, Kempharm, INC is an active lobbying client. Their lobbying covers 2 issue areas.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $70K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Kempharm, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy
Prodrug therapies and improving abuse deterrence and consumer safety
Anti-opioid abuse deterrent legislation
FDA regulation of opioid abuse deterrent formulations
Prodrug therapies and improving abuse deterrence and consumer safety
Anti-opioid abuse deterrent legislation
H.R. 6 (SUPPORT for Patients and Communities Act), provisions relating to HHS study on abu
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.